Silverarc Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-39,733
| Closed | -$403K | – | 72 |
|
|
2024
Q4 | $403K | Buy |
39,733
+2,502
| +7% | +$25.4K | 0.09% | 55 |
|
|
2024
Q3 | $464K | Hold |
37,231
| – | – | 0.1% | 63 |
|
|
2024
Q2 | $485K | Hold |
37,231
| – | – | 0.11% | 62 |
|
|
2024
Q1 | $843K | Sell |
37,231
-233
| -0.6% | -$5.28K | 0.23% | 60 |
|
|
2023
Q4 | $486K | Hold |
37,464
| – | – | 0.14% | 60 |
|
|
2023
Q3 | $753K | Buy |
37,464
+2,865
| +8% | +$57.6K | 0.23% | 55 |
|
|
2023
Q2 | $929K | Sell |
34,599
-68,163
| -66% | -$1.83M | 0.29% | 55 |
|
|
2023
Q1 | $6M | Buy |
+102,762
| New | +$6M | 2.48% | 14 |
|